Loading insider details...
Beta
Latest Form 4 (May 28, 2026): Grant/Award of 8,000 VIR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| Jun 7, 2025 | Vir Biotechnology, Inc. (VIR) | Other (see footnotes) | 10,667 | n/a |
| Jun 2, 2025 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| Aug 20, 2024 | Morphic Holding, Inc. (MORF) | Disposition to Issuer | 24,000 | n/a |
| Jul 1, 2024 | Kronos Bio, Inc. (KRON) | Purchase | 410,848 | $478.8K |
| Jun 12, 2024 | Kronos Bio, Inc. (KRON) | Purchase | 1,378,901 | $1.21M |
| Jun 5, 2024 | Morphic Holding, Inc. (MORF) | Grant/Award | 23,168 | n/a |
| May 31, 2024 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 16,000 | n/a |
| Feb 16, 2024 | Kronos Bio, Inc. (KRON) | Grant/Award | 270,339 | n/a |